Wordt geladen...
P04.07 Relapse in a paucisymptomatic form of multiple sclerosis in a patient treated with nivolumab
INTRODUCTION: The successful clinical application of immune checkpoint-blockade therapies, as anti-CTLA4, anti-PDL1 and antiPDL2 antibodies, is changing the way to treat patients with cancer. Nivolumab is an anti-PD-1 antibody with promising efficacy in a broad of neoplasias. During treatment with t...
Bewaard in:
| Gepubliceerd in: | Neuro Oncol |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5782583/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now188.085 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|